HSKA - ヘスカ (Heska Corporation) ヘスカ

 HSKAのチャート


 HSKAの企業情報

symbol HSKA
会社名 Heska Corp. (ヘスカ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ヘスカ(Heska Corporation)は獣医向けの診断と特殊製品の販売に従事する会社。同社はコアコンパニオンアニマルヘルス(CCA)とその他のワクチン、医薬品と製品(OVP)事業という2つの事業セグメントを運営する。CCA事業セグメントは、主に犬と猫に使用される血液検査機器と消耗品、デジタル画像製品、ソフトウェアとサービス、ローカルとクラウドベースのデータサービス、アレルギー検査と免疫療法、並びに病院内診断テストとワーム予防製品などの単回使用製品を含む。OVP事業セグメントは、牛用、並びに馬、ブタ、鳥類、猫及び犬を含む他の種の動物向けの個人ラベルワクチンと薬品を含む。すべてのOVP製品はサードパーティのラベルの下で第三者によって販売される。同社は、犬や猫のヘルスケア分野における獣医師へのサポートを中心とする。同社は、獣医向けの血液検査と他の器具のラインを提供し、他の動物健康会社向けの生物学的製剤と医薬品を生産する。   ヘスカは米国の獣医製品メ―カ―。動物向けに医薬品ヘルスケア製品の開発、製造、販売、サポ―トを行う。犬・猫などのペット動物を対象に血液検査機器、フィラリア診断テスト、フィラリア予防製品、アレルギ―免疫療法製品、アレルギ―検査、およびデジタル画像製品を提供する。また、牛や小型哺乳類を含む他の動物向けにワクチンや医薬品を提供する。   Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.
本社所在地 3760 Rocky Mountain Avenue Loveland CO 80538 USA
代表者氏名 Sharon J. Larson シャロンJ.ラーソン
代表者役職名 Independent Chairman of the Board
電話番号 +1 970-493-7272
設立年月日 1988年
市場名 NASDAQ Small Cap
ipoyear 1997年
従業員数 345人
url www.heska.com
nasdaq_url https://www.nasdaq.com/symbol/hska
adr_tso
EBITDA EBITDA(百万ドル) 19.84200
終値(lastsale) 97.06
時価総額(marketcap) 727735594.46
時価総額 時価総額(百万ドル) 751.87850
売上高 売上高(百万ドル) 127.05000
企業価値(EV) 企業価値(EV)(百万ドル) 744.22250
当期純利益 当期純利益(百万ドル) 11.96300
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Heska Corp revenues decreased 1% to $62.4M. Net income decreased 49% to $4.1M. Revenues reflect Other Vaccines Pharmaceuticals_Products segment decrease of 32% to $9M. Net income also reflects Other Vaccines Pharmaceuticals_Products segment loss totaling $712K vs. income of $3.7M. Basic Earnings per Share excluding Extraordinary Items decreased from $1.13 to $0.57.

 HSKAのテクニカル分析


 HSKAのニュース

   Heska Corporation Reports Second Quarter 2020 Results  2020/08/04 12:00:00 PR Newswire
LOVELAND, Colo., Aug. 4, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its second quarter ended June…
   Heska Corporation Second Quarter 2020 Financial Results and Earnings Call Scheduled for August 4, 2020  2020/07/16 12:00:00 PR Newswire
LOVELAND, Colo., July 16, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, plans to report its second quarter 2020 financial performance in a press release before the market opens…
   Global Veterinary PoC Diagnostics Market Assessment 2020-2025 with Profilings of 20 Major Players Including Zoetis, IDEXX Labs, Heska Corp, Virbac, and Thermo Fisher Scientific - ResearchAndMarkets.com  2020/06/02 12:47:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User, Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR
   Heska (HSKA) Reports Q1 Loss, Misses Revenue Estimates  2020/05/07 13:25:06 Zacks Investment Research
Heska (HSKA) delivered earnings and revenue surprises of 44.00% and -8.40%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Heska Corporation Reports First Quarter 2020 Results  2020/05/07 12:00:00 PR Newswire
LOVELAND, Colo., May 7, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, today reported financial results for its first quarter ended March 31, 2020. The Company reports two segments:…
   Heska Corporation Reports Second Quarter 2020 Results  2020/08/04 12:00:00 PR Newswire
LOVELAND, Colo., Aug. 4, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its second quarter ended June…
   Heska Corporation Second Quarter 2020 Financial Results and Earnings Call Scheduled for August 4, 2020  2020/07/16 12:00:00 PR Newswire
LOVELAND, Colo., July 16, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, plans to report its second quarter 2020 financial performance in a press release before the market opens…
   Global Veterinary PoC Diagnostics Market Assessment 2020-2025 with Profilings of 20 Major Players Including Zoetis, IDEXX Labs, Heska Corp, Virbac, and Thermo Fisher Scientific - ResearchAndMarkets.com  2020/06/02 12:47:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User, Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR
   Heska (HSKA) Reports Q1 Loss, Misses Revenue Estimates  2020/05/07 13:25:06 Zacks Investment Research
Heska (HSKA) delivered earnings and revenue surprises of 44.00% and -8.40%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Heska Corporation Reports First Quarter 2020 Results  2020/05/07 12:00:00 PR Newswire
LOVELAND, Colo., May 7, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, today reported financial results for its first quarter ended March 31, 2020. The Company reports two segments:…
   Heska (HSKA) Reports Q1 Loss, Misses Revenue Estimates  2020/05/07 13:25:06 Zacks Investment Research
Heska (HSKA) delivered earnings and revenue surprises of 44.00% and -8.40%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Heska Corporation Reports First Quarter 2020 Results  2020/05/07 12:00:00 PR Newswire
LOVELAND, Colo., May 7, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, today reported financial results for its first quarter ended March 31, 2020. The Company reports two segments:…
   Heska Corporation Expands Executive Leadership Team  2020/04/22 12:00:00 PR Newswire
LOVELAND, Colo., April 22, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today that it will expand its leadership team, adding a Chief Commercial Officer, a Chief…
   Heska Corporation First Quarter 2020 Financial Results and Earnings Call Scheduled for May 7, 2020  2020/04/16 12:00:00 PR Newswire
LOVELAND, Colo., April 16, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to report its first quarter 2020 financial performance in a press release on Thursday, May 7, 2020 before…
   Covetrus Completes Sale of scil animal care to Heska  2020/04/01 13:00:00 Business Wire
PORTLAND, Maine--(BUSINESS WIRE)--Covetrus announced that it has completed the sale of its scil animal care business to Heska Corporation.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ヘスカ HSKA Heska Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)